Igor S. Bazin
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 10
- Pancreatic and Hepatic Oncology Research 9
- Colorectal Cancer Treatments and Studies 1
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Co-authors
- Valery P. Shelepov (1 shared paper)O. I. Serdyuk (1 shared paper)August M. Garin (1 shared paper)A. V. Lichtenstein (1 shared paper)Knysh Vi (1 shared paper)Г. И. Потапова (1 shared paper)Hovsep S. Melkonyan (1 shared paper)Samuil R. Umansky (1 shared paper)
In The Last Decade
Igor S. Bazin
27 papers receiving 922 citations
Igor S. Bazin's Hit Papers
Peers
Comparison fields: 5 of 48
- Cancer Research 118
- Oncology 157
- Pulmonary and Respiratory Medicine 224
- Pediatrics, Perinatology and Child Health 29
- Hepatology 20
Countries citing papers authored by Igor S. Bazin
This map shows the geographic impact of Igor S. Bazin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor S. Bazin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor S. Bazin more than expected).
Fields of papers citing papers by Igor S. Bazin
This network shows the impact of papers produced by Igor S. Bazin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor S. Bazin. The network helps show where Igor S. Bazin may publish in the future.
Co-authors
The 25 scholars most cited alongside Igor S. Bazin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 324 | |
| 2 | FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma Hit paper breakdown → | 2021 | 300 |
| 3 | 2018 | 81 | |
| 4 | 2010 | 53 | |
| 5 | 2016 | 52 | |
| 6 | 2016 | 46 | |
| 7 | 2016 | 19 | |
| 8 | 2007 | 17 | |
| 9 | 2023 | 5 | |
| 10 | 2025 | 5 | |
| 11 | 2019 | 4 | |
| 12 | 2021 | 4 | |
| 13 | 2023 | 4 | |
| 14 | 1999 | 3 | |
| 15 | 2016 | 3 | |
| 16 | 2018 | 3 | |
| 17 | 2022 | 3 | |
| 18 | 2016 | 2 | |
| 19 | 2016 | 2 | |
| 20 | Clinical Predictors of Second-Line Chemotherapy Benefit in Patients with Pancreatic Cancer | 2017 | 2 |
About Igor S. Bazin
Igor S. Bazin is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Surgery and Biotechnology, having authored 33 papers that have together received 939 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Gastric Cancer Management and Outcomes (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Microbial Inactivation Methods (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Cancer Research (118 citations), Oncology (157 citations), Pulmonary and Respiratory Medicine (224 citations), Pediatrics, Perinatology and Child Health (29 citations) and Hepatology (20 citations). Igor S. Bazin has collaborated with scholars based in Russia, Germany and Czechia. Frequent co-authors include Valery P. Shelepov, O. I. Serdyuk, August M. Garin, A. V. Lichtenstein, Knysh Vi, Г. И. Потапова, Hovsep S. Melkonyan, Samuil R. Umansky, Irina V. Botezatu and Igor Bondarenko. Their work appears in journals such as Annals of Oncology, Journal of Hepatology, Clinical Chemistry, Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.